Mouse Mesenchymal Stem Cells Inhibit High Endothelial Cell Activation and Lymphocyte Homing to Lymph Nodes by Releasing TIMP-1

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2016 Feb 23

PMID 26898191

Citations 30

Authors

L Zanotti

R Angioni

B Cali

C Soldani

C Ploia

F Moalli

M Gargesha

G DAmico

S Elliman

G Tedeschi

E Maffioli

A Negri

S Zacchigna

A Sarukhan

J V Stein

A Viola

Affiliations

Soon will be listed here.

Abstract

Mesenchymal stem cells (MSC) represent a promising therapeutic approach in many diseases in view of their potent immunomodulatory properties, which are only partially understood. Here, we show that the endothelium is a specific and key target of MSC during immunity and inflammation. In mice, MSC inhibit activation and proliferation of endothelial cells in remote inflamed lymph nodes (LNs), affect elongation and arborization of high endothelial venules (HEVs) and inhibit T-cell homing. The proteomic analysis of the MSC secretome identified the tissue inhibitor of metalloproteinase-1 (TIMP-1) as a potential effector molecule responsible for the anti-angiogenic properties of MSC. Both in vitro and in vivo, TIMP-1 activity is responsible for the anti-angiogenic effects of MSC, and increasing TIMP-1 concentrations delivered by an Adeno Associated Virus (AAV) vector recapitulates the effects of MSC transplantation on draining LNs. Thus, this study discovers a new and highly efficient general mechanism through which MSC tune down immunity and inflammation, identifies TIMP-1 as a novel biomarker of MSC-based therapy and opens the gate to new therapeutic approaches of inflammatory diseases.

Citing Articles

Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges.

Shan Y, Zhang M, Tao E, Wang J, Wei N, Lu Y Signal Transduct Target Ther. 2024; 9(1):242.

PMID: 39271680 PMC: 11399464. DOI: 10.1038/s41392-024-01936-8.

Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions.

Caruso L, Fields M, Rimondi E, Zauli G, Longo G, Marcuzzi A Int J Mol Sci. 2024; 25(4).

PMID: 38396799 PMC: 10889839. DOI: 10.3390/ijms25042124.

The Role of Matrix Metalloproteinases in Hemorrhagic Transformation in the Treatment of Stroke with Tissue Plasminogen Activator.

Babenko V, Fedulova K, Silachev D, Rahimi-Moghaddam P, Kalyuzhnaya Y, Demyanenko S J Pers Med. 2023; 13(7).

PMID: 37511788 PMC: 10381732. DOI: 10.3390/jpm13071175.

The Therapeutic Effects of Mesenchymal Stem Cells and their Secretome on Oral Squamous Cell Carcinoma.

Ataei A, Azizi M, Hajisadeghi S, Madani M, Khorami M, Hassantash S Curr Mol Med. 2023; 24(10):1195-1207.

PMID: 37366360 DOI: 10.2174/1566524023666230627151809.

Current Advancements in Spinal Cord Injury Research-Glial Scar Formation and Neural Regeneration.

Clifford T, Finkel Z, Rodriguez B, Joseph A, Cai L Cells. 2023; 12(6).

PMID: 36980193 PMC: 10046908. DOI: 10.3390/cells12060853.

References

Jung K, Liu X, Chirco R, Fridman R, Kim H . Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. EMBO J. 2006; 25(17):3934-42. PMC: 1560352. DOI: 10.1038/sj.emboj.7601281. View

Caplan A . Mesenchymal stem cells. J Orthop Res. 1991; 9(5):641-50. DOI: 10.1002/jor.1100090504. View

Lee H, Ko J, Ko A, Kim M, Wee W, Oh J . Intravenous infusion of mesenchymal stem/stromal cells decreased CCR7(+) antigen presenting cells in mice with corneal allotransplantation. Curr Eye Res. 2014; 39(8):780-9. DOI: 10.3109/02713683.2013.877489. View

Lin K, Fulton L, Berginski M, West M, Taylor N, Moran T . Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD. Blood. 2014; 123(10):1604-14. PMC: 3945868. DOI: 10.1182/blood-2013-09-526020. View

Koch A, Halloran M, Haskell C, Shah M, Polverini P . Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature. 1995; 376(6540):517-9. DOI: 10.1038/376517a0. View

Frenette P, Pinho S, Lucas D, Scheiermann C . Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu Rev Immunol. 2013; 31:285-316. DOI: 10.1146/annurev-immunol-032712-095919. View

Gargesha M, Qutaish M, Roy D, Steyer G, Watanabe M, Wilson D . Visualization of color anatomy and molecular fluorescence in whole-mouse cryo-imaging. Comput Med Imaging Graph. 2010; 35(3):195-205. PMC: 3049862. DOI: 10.1016/j.compmedimag.2010.10.003. View

Reed M, Koike T, Sadoun E, Sage E, Puolakkainen P . Inhibition of TIMP1 enhances angiogenesis in vivo and cell migration in vitro. Microvasc Res. 2003; 65(1):9-17. DOI: 10.1016/s0026-2862(02)00026-2. View

Boscacci R, Pfeiffer F, Gollmer K, Sevilla A, Martin A, Soriano S . Comprehensive analysis of lymph node stroma-expressed Ig superfamily members reveals redundant and nonredundant roles for ICAM-1, ICAM-2, and VCAM-1 in lymphocyte homing. Blood. 2010; 116(6):915-25. PMC: 3324225. DOI: 10.1182/blood-2009-11-254334. View

10.

Crisan M, Yap S, Casteilla L, Chen C, Corselli M, Park T . A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008; 3(3):301-13. DOI: 10.1016/j.stem.2008.07.003. View

11.

Lozito T, Tuan R . Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs. J Cell Physiol. 2010; 226(2):385-96. DOI: 10.1002/jcp.22344. View

12.

Sensebe L, Krampera M, Schrezenmeier H, Bourin P, Giordano R . Mesenchymal stem cells for clinical application. Vox Sang. 2009; 98(2):93-107. DOI: 10.1111/j.1423-0410.2009.01227.x. View

13.

Baer C, Squadrito M, Iruela-Arispe M, de Palma M . Reciprocal interactions between endothelial cells and macrophages in angiogenic vascular niches. Exp Cell Res. 2013; 319(11):1626-34. PMC: 8014949. DOI: 10.1016/j.yexcr.2013.03.026. View

14.

Pober J, Sessa W . Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007; 7(10):803-15. DOI: 10.1038/nri2171. View

15.

Zhou Z, Connell M, MacEwan D . TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell Signal. 2007; 19(6):1238-48. DOI: 10.1016/j.cellsig.2006.12.013. View

16.

OConnell K, Edidin M . A mouse lymphoid endothelial cell line immortalized by simian virus 40 binds lymphocytes and retains functional characteristics of normal endothelial cells. J Immunol. 1990; 144(2):521-5. View

17.

Webster B, Ekland E, Agle L, Chyou S, Ruggieri R, Lu T . Regulation of lymph node vascular growth by dendritic cells. J Exp Med. 2006; 203(8):1903-13. PMC: 2118366. DOI: 10.1084/jem.20052272. View

18.

Zgraggen S, Ochsenbein A, Detmar M . An important role of blood and lymphatic vessels in inflammation and allergy. J Allergy (Cairo). 2013; 2013:672381. PMC: 3574757. DOI: 10.1155/2013/672381. View

19.

Groh M, Maitra B, Szekely E, Koc O . Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol. 2005; 33(8):928-34. DOI: 10.1016/j.exphem.2005.05.002. View

20.

Medzhitov R . Origin and physiological roles of inflammation. Nature. 2008; 454(7203):428-35. DOI: 10.1038/nature07201. View